{"id":"https://openalex.org/W4409195656","doi":"https://doi.org/10.1016/j.clml.2025.03.013","title":"Ranking the Importance of Prognostic Factors for Relapsed/Refractory Multiple Myeloma: International Physician Panel Consensus Following a Systematic Literature Review","display_name":"Ranking the Importance of Prognostic Factors for Relapsed/Refractory Multiple Myeloma: International Physician Panel Consensus Following a Systematic Literature Review","publication_year":2025,"publication_date":"2025-04-06","ids":{"openalex":"https://openalex.org/W4409195656","doi":"https://doi.org/10.1016/j.clml.2025.03.013","pmid":"https://pubmed.ncbi.nlm.nih.gov/40410023"},"language":"en","primary_location":{"id":"doi:10.1016/j.clml.2025.03.013","doi":"https://doi.org/10.1016/j.clml.2025.03.013","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clml.2025.03.013","pdf_url":"https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(25)00105-3/pdf","source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(25)00105-3/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026574827","display_name":"Shaji Kunnathu Kumar","orcid":"https://orcid.org/0000-0001-5392-9284","observed_orcids":["https://orcid.org/0000-0001-5392-9284","https://orcid.org/0000-0003-3013-7174"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Shaji Kumar","raw_affiliation_strings":["Mayo Clinic, Rochester, MN. Electronic address: Kumar.Shaji@mayo.edu"],"raw_orcid":"https://orcid.org/0000-0001-5392-9284","affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN. Electronic address: Kumar.Shaji@mayo.edu","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048560248","display_name":"Xavier P Leleu","orcid":"https://orcid.org/0000-0002-9822-4170","observed_orcids":["https://orcid.org/0000-0002-9822-4170"]},"institutions":[{"id":"https://openalex.org/I4210111187","display_name":"Centre Hospitalier Universitaire de Poitiers","ror":"https://ror.org/029s6hd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210111187"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Xavier Leleu","raw_affiliation_strings":["Poitiers University Hospital, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Poitiers University Hospital, Poitiers, France","institution_ids":["https://openalex.org/I4210111187"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022522496","display_name":"Katja Christina Weisel","orcid":"https://orcid.org/0000-0001-9422-6614","observed_orcids":["https://orcid.org/0000-0001-9422-6614"]},"institutions":[{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Katja C. Weisel","raw_affiliation_strings":["University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082564837","display_name":"Rakesh Popat","orcid":"https://orcid.org/0000-0001-6553-4618","observed_orcids":["https://orcid.org/0000-0001-6553-4618"]},"institutions":[{"id":"https://openalex.org/I1340918713","display_name":"University College London Hospitals NHS Foundation Trust","ror":"https://ror.org/042fqyp44","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rakesh Popat","raw_affiliation_strings":["University College London Hospitals NHS Foundation Trust, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London Hospitals NHS Foundation Trust, London, UK","institution_ids":["https://openalex.org/I1340918713"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001617887","display_name":"Beatrice Suero","orcid":"https://orcid.org/0009-0009-3134-5136","observed_orcids":["https://orcid.org/0009-0009-3134-5136"]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Beatrice Suero","raw_affiliation_strings":["EVERSANA, Burlington, ON, Canada"],"raw_orcid":"https://orcid.org/0009-0009-3134-5136","affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, ON, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066176518","display_name":"Samantha Craigie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Samantha Craigie","raw_affiliation_strings":["EVERSANA, Burlington, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, ON, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029755388","display_name":"Paul J. Spin","orcid":"https://orcid.org/0000-0002-4622-3547","observed_orcids":["https://orcid.org/0000-0002-4622-3547"]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Paul Spin","raw_affiliation_strings":["EVERSANA, Burlington, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, ON, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Leena Patel","orcid":"https://orcid.org/0000-0003-3998-736X","observed_orcids":["https://orcid.org/0000-0003-3998-736X"]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Leena Patel","raw_affiliation_strings":["EVERSANA, Burlington, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0003-3998-736X","affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, ON, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012300936","display_name":"Abril Oliva Ramirez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153140","display_name":"EVERSANA (Canada)","ror":"https://ror.org/04vgfdj66","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210153140"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Abril Oliva Ramirez","raw_affiliation_strings":["EVERSANA, Burlington, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EVERSANA, Burlington, ON, Canada","institution_ids":["https://openalex.org/I4210153140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047329021","display_name":"Christian Hampp","orcid":"https://orcid.org/0000-0002-1094-6364","observed_orcids":["https://orcid.org/0000-0002-1094-6364"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christian Hampp","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, NY"],"raw_orcid":"https://orcid.org/0000-0002-1094-6364","affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076066320","display_name":"Wenzhen Ge","orcid":"https://orcid.org/0000-0001-6106-4030","observed_orcids":["https://orcid.org/0000-0001-6106-4030"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenzhen Ge","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112646814","display_name":"Qiufei Ma","orcid":"https://orcid.org/0000-0003-4270-3487","observed_orcids":["https://orcid.org/0000-0003-4270-3487"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiufei Ma","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028046297","display_name":"Sundar Jagannath","orcid":"https://orcid.org/0000-0003-2934-6518","observed_orcids":["https://orcid.org/0000-0003-2934-6518"]},"institutions":[{"id":"https://openalex.org/I1324220072","display_name":"Mount Sinai Hospital","ror":"https://ror.org/01zkyz108","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I1324220072"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sundar Jagannath","raw_affiliation_strings":["Mount Sinai Hospital, New York City, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Sinai Hospital, New York City, NY","institution_ids":["https://openalex.org/I1324220072"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5026574827"],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":{"value":3890,"currency":"USD","value_usd":3890},"fwci":1.7703,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.84896347,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"25","issue":"10","first_page":"730","last_page":"738.e11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":1.0},{"id":"https://openalex.org/keywords/expert-consensus","display_name":"expert consensus","score":0.6470000147819519},{"id":"https://openalex.org/keywords/cytogenetic-risk","display_name":"cytogenetic risk","score":0.8029999732971191},{"id":"https://openalex.org/keywords/age","display_name":"age","score":0.7519999742507935},{"id":"https://openalex.org/keywords/disease-stage","display_name":"disease stage","score":0.996999979019165},{"id":"https://openalex.org/keywords/performance-status","display_name":"performance status","score":1.0},{"id":"https://openalex.org/keywords/extramedullary-disease","display_name":"extramedullary disease","score":0.9950000047683716},{"id":"https://openalex.org/keywords/plasmacytoma","display_name":"plasmacytoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8980000019073486},{"id":"https://openalex.org/keywords/objective-response","display_name":"objective response","score":0.9810000061988831},{"id":"https://openalex.org/keywords/indirect-treatment-comparison","display_name":"indirect treatment comparison","score":0.734000027179718},{"id":"https://openalex.org/keywords/external-control-arm","display_name":"external control arm","score":0.7289999723434448}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9493070244789124},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6634679436683655},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5344539880752563},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5107898712158203},{"id":"https://openalex.org/C189430467","wikidata":"https://www.wikidata.org/wiki/Q7293293","display_name":"Ranking (information retrieval)","level":2,"score":0.49366435408592224},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36866137385368347},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3681643009185791},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.07263055443763733},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.clml.2025.03.013","doi":"https://doi.org/10.1016/j.clml.2025.03.013","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clml.2025.03.013","pdf_url":"https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(25)00105-3/pdf","source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},{"id":"pmid:40410023","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40410023","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical lymphoma, myeloma & leukemia","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.clml.2025.03.013","doi":"https://doi.org/10.1016/j.clml.2025.03.013","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clml.2025.03.013","pdf_url":"https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(25)00105-3/pdf","source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4409195656.pdf","grobid_xml":"https://content.openalex.org/works/W4409195656.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W2016418114","https://openalex.org/W2095255742","https://openalex.org/W2161374186","https://openalex.org/W2169205464","https://openalex.org/W2216303864","https://openalex.org/W2299177375","https://openalex.org/W2650689221","https://openalex.org/W2948551797","https://openalex.org/W2979807505","https://openalex.org/W3100433875","https://openalex.org/W3134103265","https://openalex.org/W3212185035","https://openalex.org/W4211058750","https://openalex.org/W4282033105","https://openalex.org/W4285043563","https://openalex.org/W4309506283","https://openalex.org/W4311900566","https://openalex.org/W4313278754","https://openalex.org/W4323045882","https://openalex.org/W4360806629","https://openalex.org/W4367299334","https://openalex.org/W4379281020","https://openalex.org/W4379281157","https://openalex.org/W4379281322","https://openalex.org/W4379282037","https://openalex.org/W4379282038","https://openalex.org/W4379282636","https://openalex.org/W4379332738","https://openalex.org/W4379341611","https://openalex.org/W4379662253","https://openalex.org/W4385839624","https://openalex.org/W4389902541","https://openalex.org/W4390988769","https://openalex.org/W4392238297","https://openalex.org/W4393988385","https://openalex.org/W4399325529","https://openalex.org/W4399716637","https://openalex.org/W4401876654","https://openalex.org/W6856111612"],"related_works":["https://openalex.org/W4387003616","https://openalex.org/W4386101150","https://openalex.org/W4413103009","https://openalex.org/W3189251519","https://openalex.org/W7164202081","https://openalex.org/W7038371165","https://openalex.org/W4297904990","https://openalex.org/W2270864458","https://openalex.org/W2404858784","https://openalex.org/W2400878482"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,201],"increasing":[2],"use":[3],"of":[4,48,117,136,150,174,178,228,245],"single-arm":[5],"and":[6,37,50,59,94,104,122,188,222],"nonrandomized":[7],"trial":[8],"designs":[9],"in":[10,67,129,158,190,197,235,242],"oncology":[11],"aims":[12],"to":[13,17,45,56,64,144,238],"expedite":[14],"patient":[15],"access":[16],"novel":[18],"treatments.":[19],"To":[20,77],"contextualize":[21],"their":[22,127],"results":[23],"using":[24,108],"strategies":[25],"such":[26],"as":[27],"external":[28],"control":[29],"arms":[30],"or":[31],"indirect":[32],"treatment":[33,65,240],"comparisons,":[34],"prespecification":[35],"of,":[36],"subsequent":[38],"adjustment":[39],"for,":[40],"prognostic":[41,61,80,106,211,230],"factors":[42,62,166,180,231],"is":[43],"required":[44],"ensure":[46],"comparability":[47],"populations":[49],"avoid":[51],"bias.":[52],"This":[53,226],"study":[54],"aimed":[55],"systematically":[57],"identify":[58,79],"rank":[60],"relevant":[63],"outcomes":[66],"patients":[68,101],"with":[69,88,102,169,182],"relapsed/refractory":[70],"multiple":[71,118],"myeloma":[72,119],"(RRMM).":[73],"MATERIALS":[74],"AND":[75],"METHODS:":[76],"comprehensively":[78],"factors,":[81],"a":[82],"systematic":[83,160],"literature":[84,161],"review":[85],"was":[86,139],"conducted":[87,140],"databases":[89],"searched":[90],"between":[91],"January":[92],"2016":[93],"April":[95],"2022.":[96],"Clinical":[97],"studies":[98,156,194],"enrolling":[99],"adult":[100],"RRMM":[103,229],"assessing":[105],"significance":[107],"adjusted":[109],"analyses":[110,237],"were":[111,195],"included.":[112],"Subsequently,":[113],"an":[114],"international":[115],"panel":[116,203],"experts":[120],"confirmed":[121],"ranked":[123],"these":[124],"variables":[125],"by":[126],"importance":[128],"predicting":[130],"clinical":[131],"outcomes.":[132],"A":[133,176],"structured":[134],"series":[135],"expert":[137],"consultations":[138],"from":[141],"November":[142],"2022":[143],"February":[145],"2023,":[146],"including":[147],"2":[148,193],"rounds":[149],"consensus":[151],"meetings.":[152],"RESULTS:":[153],"Of":[154],"125":[155],"included":[157,196],"the":[159,198,207,243],"review,":[162],"112":[163],"described":[164],"97":[165],"significantly":[167],"associated":[168,181],"at":[170,191],"least":[171,192],"1":[172],"outcome":[173],"interest.":[175],"total":[177],"25":[179],"overall":[183],"survival":[184],"and/or":[185],"objective":[186],"response":[187],"reported":[189],"ranking":[199],"process.":[200],"physician":[202],"unanimously":[204],"agreed":[205],"on":[206],"6":[208],"most":[209],"important":[210],"factors:":[212],"cytogenetic":[213],"risk,":[214],"age,":[215],"refractory":[216],"status,":[217,221],"disease":[218],"stage,":[219],"performance":[220],"extramedullary":[223],"disease/plasmacytoma.":[224],"CONCLUSION:":[225],"list":[227],"can":[232],"be":[233],"used":[234],"comparative":[236],"assess":[239],"effectiveness":[241],"absence":[244],"head-to-head":[246],"trials.":[247]},"counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-04-06T00:00:00"}